Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Diseases

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 157 articles: HTML format

Single Articles

November 2022
1. CHENG S, Yu E, Garacci Z, Erwin AL, et al
   Prevalence of Undiagnosed Acute Hepatic Porphyria in Cyclic Vomiting Syndrome and Overlap in Clinical Symptoms.
   Dig Dis Sci. 2022 Nov 16. pii: 10.1007/s10620-022-07756.
   PubMed     Abstract available
   
   
   
2. HORVATITS T, Mahmud N, Serper M, Seiz O, et al
   MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
   Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07744.
   PubMed     Abstract available
   
   
   
3. CURRAN C, Priest M, Datta S, Forrest EH, et al
   Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
   Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07731.
   PubMed     Abstract available
   
   
   
4. INOUE T, Kitano R, Ibusuki M, Sakamoto K, et al
   Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting Without Dilation Device Application for Malignant Distal Biliary Obstruction in Pancreatic Cancer.
   Dig Dis Sci. 2022 Nov 9. pii: 10.1007/s10620-022-07749.
   PubMed     Abstract available
   
   
   
5. TAPPER EB, Zhao Z, Mazumder N, Parikh ND, et al
   Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
   Dig Dis Sci. 2022;67:5327-5335.
   PubMed     Abstract available
   
   
   
6. SARAIREH H, Abdelfattah T, Hassouneh R, Lippman R, et al
   "Wet Heparin" and "Wet Saline" EUS-Guided Liver Biopsy Techniques Both Provide High Rates of Specimen Adequacy for Benign Parenchymal Liver Disease.
   Dig Dis Sci. 2022;67:5256-5261.
   PubMed     Abstract available
   
   
   
7. YEBOAH-KORANG A, Memon A, Patel N, Portocarrero-Castillo A, et al
   Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
   Dig Dis Sci. 2022;67:5262-5271.
   PubMed     Abstract available
   
   
   
8. CARDOSO AC, Tovo CV, Leite NC, El Bacha IA, et al
   Validation and Performance of FibroScan(R)-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
   Dig Dis Sci. 2022;67:5272-5279.
   PubMed     Abstract available
   
   
   October 2022
9. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
   Correction: Comparing Predictability of Noninvasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
   Dig Dis Sci. 2022 Oct 17. pii: 10.1007/s10620-022-07683.
   PubMed    
   
   
   
10. SCHEINBERG AR, John BV
    MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?
    Dig Dis Sci. 2022;67:4606-4608.
    PubMed    
    
    
    
11. KIM H, Lee CJ, Ahn SH, Lee KS, et al
    MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.
    Dig Dis Sci. 2022;67:4919-4928.
    PubMed     Abstract available
    
    
    
12. GIRI S, Darak H, Kasturi S
    Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious.
    Dig Dis Sci. 2022;67:4962-4964.
    PubMed    
    
    
    
13. ASHOURI Y, Hsu CH, Riall TS, Konstantinidis IT, et al
    Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Liver Failure After Resection of Colorectal Liver Metastases.
    Dig Dis Sci. 2022;67:4950-4958.
    PubMed     Abstract available
    
    
    September 2022
14. BENSON M, Gopal D, Pfau P
    Electronic Health Record Work Demands for Gastroenterology and Hepatology Providers: A Prospective Use Analysis and Survey Study.
    Dig Dis Sci. 2022 Sep 28. pii: 10.1007/s10620-022-07691.
    PubMed     Abstract available
    
    
    
15. SINGH A, De A, Singh MP, Rathi S, et al
    Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
    Dig Dis Sci. 2022 Sep 25. pii: 10.1007/s10620-022-07641.
    PubMed     Abstract available
    
    
    
16. HARTGERINK C, Nimri FM, Zuchelli T, Jafri SM, et al
    Band Ligation Can Be Used to Treat Barrett's Esophagus and Concurrent Esophageal Varices: A Case Series.
    Dig Dis Sci. 2022 Sep 21. pii: 10.1007/s10620-022-07696.
    PubMed     Abstract available
    
    
    
17. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
    External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
    Dig Dis Sci. 2022;67:4581-4589.
    PubMed     Abstract available
    
    
    August 2022
18. AMES PRJ, D'Andrea G, Arcaro A, Marottoli V, et al
    Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
    Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07666.
    PubMed     Abstract available
    
    
    
19. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
    Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
    Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
    PubMed     Abstract available
    
    
    
20. FERREIRA RD, John BV
    Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
    PubMed    
    
    
    
21. SAKANO Y, Noda T, Kobayashi S, Kitagawa A, et al
    Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.
    Dig Dis Sci. 2022;67:3817-3830.
    PubMed     Abstract available
    
    
    
22. SOBOTKA LA, Esteban J, Volk ML, Elmunzer BJ, et al
    Acute Liver Injury in Patients Hospitalized with COVID-19.
    Dig Dis Sci. 2022;67:4204-4214.
    PubMed     Abstract available
    
    
    
23. RAJAK S, Raza S, Tewari A, Sinha RA, et al
    Environmental Toxicants and NAFLD: A Neglected yet Significant Relationship.
    Dig Dis Sci. 2022;67:3497-3507.
    PubMed     Abstract available
    
    
    July 2022
24. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    PubMed     Abstract available
    
    
    
25. MANDORFER M
    Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR.
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07623.
    PubMed    
    
    
    
26. ADAMS PC
    Hepatocellular Carcinoma in Hemochromatosis: Where or When?
    Dig Dis Sci. 2022 Jul 11. pii: 10.1007/s10620-022-07609.
    PubMed    
    
    
    
27. NATARAJAN Y, Patel P, Chu J, Yu X, et al
    Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07602.
    PubMed     Abstract available
    
    
    
28. IZZY M, VanWagner LB
    Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
    PubMed    
    
    
    
29. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
    Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
    PubMed     Abstract available
    
    
    
30. RAMAI D, Facciorusso A, Singh J, Brooks OW, et al
    Endoscopic Management of Ampullary Adenomas in Familial Adenomatous Polyposis Syndrome: A Systematic Review with Pooled Analysis.
    Dig Dis Sci. 2022;67:3220-3227.
    PubMed     Abstract available
    
    
    
31. ELFEKI MA, Robles J, Akhtar Z, Ullah F, et al
    Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3333-3339.
    PubMed     Abstract available
    
    
    
32. FUNG BM, Leon DJ, Beck LN, Tabibian JH, et al
    Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease.
    Dig Dis Sci. 2022;67:2739-2753.
    PubMed     Abstract available
    
    
    
33. GARCIA CC, Piotrkowski B, Baz P, Poncino D, et al
    A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3006-3016.
    PubMed     Abstract available
    
    
    
34. THOMAIDES-BREARS HB, Alkhouri N, Allende D, Harisinghani M, et al
    Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:3366-3394.
    PubMed     Abstract available
    
    
    June 2022
35. DIJOSEPH K, Thorp A, Harrington A, Schmitz KH, et al
    Physical Activity and Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022 Jun 29. pii: 10.1007/s10620-022-07601.
    PubMed     Abstract available
    
    
    
36. VIJAYARAGHAVAN R, Sarin SK, Bharadwaj A, Anand L, et al
    Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
    Dig Dis Sci. 2022 Jun 28. pii: 10.1007/s10620-022-07596.
    PubMed     Abstract available
    
    
    
37. CHU J, Cholankeril G, Yu X, Rana A, et al
    Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC).
    Dig Dis Sci. 2022 Jun 27. pii: 10.1007/s10620-022-07565.
    PubMed     Abstract available
    
    
    
38. OHNO A, Fujimori N, Kaku T, Takamatsu Y, et al
    Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07555.
    PubMed     Abstract available
    
    
    
39. DHIR V, Bale A
    EUS-Guided Hepatico-Gastrostomy: To Dilate or Not to Dilate?
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07560.
    PubMed    
    
    
    
40. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
    Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
    Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
    PubMed     Abstract available
    
    
    
41. PAN AY, Zilberstein NF, Farnan JM, McConville JF, et al
    Recently Graduated Medical Students Lack Exposure to and Comfort with Chronic Liver Diseases.
    Dig Dis Sci. 2022;67:2081-2085.
    PubMed     Abstract available
    
    
    
42. TESTINO G, Vignoli T, Patussi V, Allosio P, et al
    Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Dig Dis Sci. 2022;67:1975-1986.
    PubMed     Abstract available
    
    
    
43. GLASS L, Asefa H, Volk M, Lok AS, et al
    Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
    Dig Dis Sci. 2022;67:2123-2133.
    PubMed     Abstract available
    
    
    
44. NABI O, Boursier J, Lacombe K, Mathurin P, et al
    Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
    Dig Dis Sci. 2022;67:2584-2593.
    PubMed     Abstract available
    
    
    
45. SIDDIQUI MA, Suresh S, Simmer S, Abu-Ghanimeh M, et al
    Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
    Dig Dis Sci. 2022;67:2577-2583.
    PubMed     Abstract available
    
    
    May 2022
46. ASOTIBE JC, Banini BA
    Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.
    PubMed    
    
    
    
47. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
    Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
    PubMed     Abstract available
    
    
    
48. AL-OBAID LN, Bazarbashi AN, Ryou M
    Variceal Bleeding: Beyond Banding.
    Dig Dis Sci. 2022;67:1442-1454.
    PubMed     Abstract available
    
    
    April 2022
49. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
    Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
    PubMed     Abstract available
    
    
    
50. ZHAO M, Ma L, Honda T, Kato A, et al
    Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
    Dig Dis Sci. 2022 Apr 10. pii: 10.1007/s10620-022-07489.
    PubMed     Abstract available
    
    
    
51. NOBARANI S, Alaei-Shahmiri F, Aghili R, Malek M, et al
    Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1389-1398.
    PubMed     Abstract available
    
    
    
52. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
    Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1379-1388.
    PubMed     Abstract available
    
    
    March 2022
53. TAKIGAWA A, Sakamori R, Tahata Y, Yoshioka T, et al
    Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller.
    Dig Dis Sci. 2022 Mar 30. pii: 10.1007/s10620-022-07455.
    PubMed     Abstract available
    
    
    
54. HENSON JB, Helzberg JH, Muir AJ
    Patient-Predicted Outcomes Are Associated with Quality of Life in Patients with Primary Sclerosing Cholangitis.
    Dig Dis Sci. 2022 Mar 28. pii: 10.1007/s10620-022-07482.
    PubMed     Abstract available
    
    
    
55. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
    Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
    Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
    PubMed     Abstract available
    
    
    
56. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    PubMed     Abstract available
    
    
    
57. SINHA A, Bhuva M, Grant C, Gimson AE, et al
    ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07416.
    PubMed     Abstract available
    
    
    
58. CHOI AY, Chang KJ, Samarasena JB, Lee JG, et al
    Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.
    Dig Dis Sci. 2022 Mar 12. pii: 10.1007/s10620-022-07418.
    PubMed     Abstract available
    
    
    
59. LEE TH, Hirshman N, Cardona DM, Berg CL, et al
    LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.
    Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07428.
    PubMed     Abstract available
    
    
    
60. ZHAO Z, Gao J, Huang S
    LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.
    Dig Dis Sci. 2022;67:925-935.
    PubMed     Abstract available
    
    
    
61. BHURWAL A, Makar M, Patel A, Mutneja H, et al
    Safety and Efficacy of Thrombin for Bleeding Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:953-963.
    PubMed     Abstract available
    
    
    February 2022
62. DIBATTISTA JV, Burkholder DA, Lok AS, Chen VL, et al
    Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort.
    Dig Dis Sci. 2022 Feb 15. pii: 10.1007/s10620-022-07415.
    PubMed     Abstract available
    
    
    
63. SINGH AD, Ford A, Lyu R, Layoun H, et al
    Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
    PubMed     Abstract available
    
    
    
64. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
    Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
    PubMed     Abstract available
    
    
    
65. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
    Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
    PubMed     Abstract available
    
    
    
66. JINDAL A, Sarin SK, Kumar M, Kumar G, et al
    Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient
    Dig Dis Sci. 2022 Feb 3. pii: 10.1007/s10620-021-07334.
    PubMed     Abstract available
    
    
    
67. GIBBS JT, Louissaint J, Tapper EB
    Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
    Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
    PubMed     Abstract available
    
    
    
68. FAUST A, Stine JG
    Time to Step It Up: Mobile Health Intervention for Lifestyle Modification in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:403-405.
    PubMed    
    
    
    
69. CHAUHAN M, Singh K, Thuluvath PJ
    Bariatric Surgery in NAFLD.
    Dig Dis Sci. 2022;67:408-422.
    PubMed     Abstract available
    
    
    
70. TINCOPA MA, Lyden A, Wong J, Jackson EA, et al
    Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:481-491.
    PubMed     Abstract available
    
    
    
71. LI Y, Chen C, Lu L, Guo W, et al
    Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife.
    Dig Dis Sci. 2022;67:689-696.
    PubMed     Abstract available
    
    
    January 2022
72. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
    Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
    PubMed     Abstract available
    
    
    
73. PARK MK, Lee YB, Moon H, Choi NR, et al
    Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation.
    Dig Dis Sci. 2022 Jan 20. pii: 10.1007/s10620-021-07365.
    PubMed     Abstract available
    
    
    
74. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    PubMed     Abstract available
    
    
    
75. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
    Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
    Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
    PubMed     Abstract available
    
    
    
76. WEGERMANN K, Wilder JM, Parish A, Niedzwiecki D, et al
    Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.
    Dig Dis Sci. 2022;67:93-99.
    PubMed     Abstract available
    
    
    
77. WAHID N, Rosenblatt R
    Disparities in Telehealth for Liver Disease: Revealing What Was Hidden in Plain Sight.
    Dig Dis Sci. 2022;67:3-5.
    PubMed    
    
    
    
78. NAJAFIAN N, Weber AT, Zuckerman JE, Zhang S, et al
    AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia.
    Dig Dis Sci. 2022;67:67-70.
    PubMed     Abstract available
    
    
    
79. KHALIFA A, Sasso R, Rockey DC
    Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
    Dig Dis Sci. 2022;67:337-343.
    PubMed     Abstract available
    
    
    
80. WANGRATTANAPRANEE P, Khrucharoen U, Jensen DM, Wongpongsalee T, et al
    Severe Upper Gastrointestinal Hemorrhage Caused by Reflux Esophagitis.
    Dig Dis Sci. 2022;67:159-169.
    PubMed     Abstract available
    
    
    December 2021
81. JOHNSON KD, Perisetti A, Goyal H, Thandassery R, et al
    Liver Biopsy in Pregnancy: Two Case Reports and Review of the Literature.
    Dig Dis Sci. 2021;66:4090-4098.
    PubMed     Abstract available
    
    
    
82. YAN Y, Xing X, Wang X, Men R, et al
    Development and Validation of an Easy-to-Use Risk Scoring System for Screening High-Risk Varices in Patients with HBV-Related Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2021;66:4518-4524.
    PubMed     Abstract available
    
    
    
83. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
    Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
    Dig Dis Sci. 2021;66:4501-4507.
    PubMed     Abstract available
    
    
    
84. DHALIWAL HS, Singh R, Abraham AM, Sharma R, et al
    Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4197-4207.
    PubMed     Abstract available
    
    
    November 2021
85. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    PubMed     Abstract available
    
    
    
86. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    PubMed     Abstract available
    
    
    
87. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
    Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
    PubMed     Abstract available
    
    
    
88. BENITEZ C
    Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.
    PubMed    
    
    
    
89. MANKA PP, Kaya E, Canbay A, Syn WK, et al
    A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3676-3688.
    PubMed     Abstract available
    
    
    
90. KOSICK HM, Keyrouz A, Adeyi O, Sebastiani G, et al
    A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4046-4057.
    PubMed     Abstract available
    
    
    
91. ABDU B, Akolkar S, Picking C, Boura J, et al
    Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2021;66:4035-4045.
    PubMed     Abstract available
    
    
    October 2021
92. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
    PubMed     Abstract available
    
    
    
93. LI W, Xue H, Li Y, Li P, et al
    HIPK3 Circular RNA Promotes Metastases of HCC Through Sponging miR-338-3p to Induce ZEB2 Expression.
    Dig Dis Sci. 2021;66:3439-3447.
    PubMed     Abstract available
    
    
    
94. STINE JG, Soriano C, Schreibman I, Rivas G, et al
    Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3604-3611.
    PubMed     Abstract available
    
    
    September 2021
95. KONG J, Liang X, Zhang J, Zeng J, et al
    Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
    Dig Dis Sci. 2021 Sep 14. pii: 10.1007/s10620-021-07248.
    PubMed     Abstract available
    
    
    
96. LI J, Lu M, Zhou Y, Bowlus CL, et al
    Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07219.
    PubMed     Abstract available
    
    
    
97. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    PubMed    
    
    
    
98. LABENZ C, Kostev K, Kaps L, Galle PR, et al
    Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany.
    Dig Dis Sci. 2021;66:3179-3185.
    PubMed     Abstract available
    
    
    
99. UFERE NN, Donlan J, Indriolo T, Richter J, et al
    Burdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers.
    Dig Dis Sci. 2021;66:2942-2955.
    PubMed     Abstract available
    
    
    August 2021
100. YOPES MC, Mozeika AM, Liebling S, Haslam A, et al
     An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals.
     Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07199.
     PubMed     Abstract available
     
     
     
101. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
     Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
     Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
     PubMed     Abstract available
     
     
     
102. LOUISSAINT J, Kassab I, Yeboah-Korang A, Fontana RJ, et al
     Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
     Dig Dis Sci. 2021 Aug 24. pii: 10.1007/s10620-021-07223.
     PubMed     Abstract available
     
     
     
103. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
     Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
     Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
     PubMed     Abstract available
     
     
     
104. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
     Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
     PubMed     Abstract available
     
     
     
105. ZHANG S, Tao X, Wang L, Chen H, et al
     Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07165.
     PubMed     Abstract available
     
     
     
106. CHEN Y, Li H, Chen D, Jiang X, et al
     Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1alpha Expression.
     Dig Dis Sci. 2021 Aug 12. pii: 10.1007/s10620-021-07202.
     PubMed     Abstract available
     
     
     
107. THAKER S, Mikolajczyk AE
     Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
     PubMed    
     
     
     
108. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
     Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
     Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
     PubMed     Abstract available
     
     
     
109. OH JH, Goh MJ, Park Y, Kim J, et al
     Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
     Dig Dis Sci. 2021;66:2816-2825.
     PubMed     Abstract available
     
     
     
110. NOZAWA H, Emoto S, Sonoda H, Kawai K, et al
     Liver Injury Among Japanese Patients Treated Using Prophylactic Enoxaparin After Colorectal Surgery.
     Dig Dis Sci. 2021;66:2805-2815.
     PubMed     Abstract available
     
     
     July 2021
111. BOCKORNY B, Bullock AJ, Abrams TA, Faintuch S, et al
     Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
     Dig Dis Sci. 2021 Jul 23. pii: 10.1007/s10620-021-07156.
     PubMed     Abstract available
     
     
     
112. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
     Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
     PubMed     Abstract available
     
     
     
113. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
     Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
     Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
     PubMed     Abstract available
     
     
     
114. BARNES EL, Grimm-Vavlitis JL, Long MD
     Impact of Virtual Interviews on Gastroenterology and Hepatology Fellowship Recruitment.
     Dig Dis Sci. 2021 Jul 15. pii: 10.1007/s10620-021-07123.
     PubMed    
     
     
     
115. LIU J, He X, Zou Y, Wang K, et al
     Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
     Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
     PubMed     Abstract available
     
     
     
116. MANKA P, Syn WK
     NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease.
     Dig Dis Sci. 2021;66:2147-2148.
     PubMed    
     
     
     
117. BOPPANA V, Sahni S, Glass J, Chang C, et al
     HCC You Cannot See.
     Dig Dis Sci. 2021;66:2185-2189.
     PubMed    
     
     
     
118. MARTIN M, Zou B, Hoang J, Jeong D, et al
     Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.
     Dig Dis Sci. 2021;66:2240-2249.
     PubMed     Abstract available
     
     
     June 2021
119. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
     Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
     Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
     PubMed     Abstract available
     
     
     
120. CHAUHAN M, Zhang T, Thuluvath PJ
     Gender Differences in Liver Transplantation Outcomes in Polycystic Liver Disease.
     Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07125.
     PubMed     Abstract available
     
     
     
121. CANCADO GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, et al
     Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
     Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07122.
     PubMed     Abstract available
     
     
     
122. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
     Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
     Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
     PubMed     Abstract available
     
     
     
123. FRENETTE CT, Levy C, Saab S
     Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
     Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
     PubMed     Abstract available
     
     
     
124. HA NB, Cho SJ, Mohamad Y, Kent D, et al
     Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
     Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
     PubMed     Abstract available
     
     
     
125. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
     International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
     Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
     PubMed     Abstract available
     
     
     
126. ZOU B, Yeo YH, Cheung R, Ingelsson E, et al
     Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
     Dig Dis Sci. 2021;66:2092-2100.
     PubMed     Abstract available
     
     
     
127. SHARMA A, Keshava SN, Eapen A, Elias E, et al
     An Update on the Management of Budd-Chiari Syndrome.
     Dig Dis Sci. 2021;66:1780-1790.
     PubMed     Abstract available
     
     
     May 2021
128. PENG X, Tian A, Li J, Mao Y, et al
     Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
     Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
     PubMed     Abstract available
     
     
     
129. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
     Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
     Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
     PubMed     Abstract available
     
     
     
130. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
     Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
     Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
     PubMed     Abstract available
     
     
     
131. LI X, Lv J, Hou L, Guo X, et al
     Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
     Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
     PubMed     Abstract available
     
     
     
132. SERPER M
     Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
     Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
     PubMed    
     
     
     
133. YU B, Zhou S, Liang H, Ye Q, et al
     Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
     Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07031.
     PubMed     Abstract available
     
     
     
134. ARTEEL GE, Singhvi A, Feldman R, Althouse AD, et al
     Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Heath Care System Cohort.
     Dig Dis Sci. 2021 May 7. pii: 10.1007/s10620-021-07010.
     PubMed     Abstract available
     
     
     
135. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
     A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
     Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
     PubMed     Abstract available
     
     
     
136. TO C, Liu L, Satoskar RS, Thuluvath PJ, et al
     Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3.
     Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07005.
     PubMed    
     
     
     
137. RICH NE, Parvathaneni A, Sen A, Odewole M, et al
     High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
     Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07001.
     PubMed     Abstract available
     
     
     
138. HASHIMOTO R, Lee DP, Samarasena JB, Chandan VS, et al
     Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study.
     Dig Dis Sci. 2021;66:1700-1706.
     PubMed     Abstract available
     
     
     April 2021
139. SCHEWE J, Makeschin MC, Khandoga A, Zhang J, et al
     To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning.
     Dig Dis Sci. 2021;66:1349-1359.
     PubMed     Abstract available
     
     
     
140. TROWELL J, Alukal J, Zhang T, Liu L, et al
     How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
     Dig Dis Sci. 2021;66:1297-1305.
     PubMed     Abstract available
     
     
     
141. SINGAL AK, Ahmed Z, Axley P, Arora S, et al
     Hospitalizations for Acute on Chronic Liver Failure at Academic Compared to Non-academic Centers Have Higher Mortality.
     Dig Dis Sci. 2021;66:1306-1314.
     PubMed     Abstract available
     
     
     February 2021
142. ZHOU SN, Pan WT, Pan MX, Luo QY, et al
     Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
     Dig Dis Sci. 2021;66:474-482.
     PubMed     Abstract available
     
     
     
143. PATIDAR KR, Davis BC, Slaven JE, Ghabril MS, et al
     Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure.
     Dig Dis Sci. 2021;66:619-627.
     PubMed     Abstract available
     
     
     January 2021
144. CAVAZZA A, McPhail MJ
     Absolutely FABulous? FABP-1 in Non-acetaminophen-related Acute Liver Failure.
     Dig Dis Sci. 2021;66:10-11.
     PubMed    
     
     
     
145. ABBASS A, Khalid S, Farooq U, Rakov N, et al
     If DILI Is Suspected, Don't Dally.
     Dig Dis Sci. 2021;66:52-55.
     PubMed    
     
     
     
146. PATEL HK, Saxena R, Rush N, Patel SK, et al
     A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?
     Dig Dis Sci. 2021;66:238-246.
     PubMed     Abstract available
     
     
     
147. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
     Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction.
     Dig Dis Sci. 2021;66:273-283.
     PubMed     Abstract available
     
     
     
148. KIM D, Yoo ER, Li AA, Tighe SP, et al
     Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
     Dig Dis Sci. 2021;66:296-307.
     PubMed     Abstract available
     
     
     August 2020
149. PHAW NA, Dyson JK, Mells G, Jones D, et al
     Understanding Fatigue in Primary Biliary Cholangitis.
     Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
     PubMed     Abstract available
     
     
     
150. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
     Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
     Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
     PubMed    
     
     
     July 2020
151. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
     Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
     Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
     PubMed     Abstract available
     
     
     June 2020
152. YUE W, Liu Y, Jiang W, Huang J, et al
     Prealbumin and D-dimer as Prognostic Indicators for Rebleeding in Patients with Nonvariceal Upper Gastrointestinal Bleeding.
     Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06420.
     PubMed     Abstract available
     
     
     
153. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
     Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
     Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
     PubMed     Abstract available
     
     
     
154. WANG CW, Lebsack A, Sudore RL, Lai JC, et al
     Low Rates of Advance Care Planning (ACP) Discussions Despite Readiness to Engage in ACP Among Liver Transplant Candidates.
     Dig Dis Sci. 2020 Jun 4. pii: 10.1007/s10620-020-06369.
     PubMed     Abstract available
     
     
     May 2020
155. SHROFF H, Rinella ME
     Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
     Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
     PubMed    
     
     
     
156. NAGAOKA K, Ogawa K, Ji C, Cao KY, et al
     Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
     Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06330.
     PubMed     Abstract available
     
     
     April 2020
157. ACHARYA C, White MB, Fagan A, Sterling RK, et al
     Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
     Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: